Detalles de la búsqueda
1.
Assessing the safety, impact and effectiveness of RTS,S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up.
Malar J
; 21(1): 132, 2022 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35468801
2.
Challenges and lessons learned from four years of planning and implementing pharmacovigilance enhancement in sub-Saharan Africa.
BMC Public Health
; 22(1): 1568, 2022 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35978276
3.
Enhancing Pharmacovigilance in Côte d'Ivoire: Impact of GSK's Training and Mentoring Pilot Project in the Abidjan Region.
Drug Saf
; 47(2): 147-159, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37966696
4.
Safety and Immunogenicity of Seven Dosing Regimens of the Candidate RTS,S/AS01E Malaria Vaccine Integrated Within an Expanded Program on Immunization Regimen: A Phase II, Single-Center, Open, Controlled Trial in Infants in Malawi.
Pediatr Infect Dis J
; 37(5): 483-491, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29432383
5.
Correction to: Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi.
Drug Saf
; 44(6): 723, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33788174
6.
Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial.
Lancet Infect Dis
; 16(10): 1134-1144, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27394191
Resultados
1 -
6
de 6
1
Próxima >
>>